TET enzymes are dioxygenases that promote DNA demethylation by oxidizing the methyl group of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC). Here we report a close correspondence between 5hmC-marked regions, chromatin accessibility and enhancer activity in B cells, and a strong enrichment for consensus binding motifs for basic region-leucine zipper (bZIP) transcription factors at TET-responsive genomic regions. Functionally, Tet2 and Tet3 regulate class switch recombination (CSR) in murine B cells by enhancing expression of Aicda, encoding the cytidine deaminase AID essential for CSR. TET enzymes deposit 5hmC, demethylate and maintain chromatin accessibility at two TET-responsive elements, TetE1 and TetE2, located within a superenhancer in the Aicda locus. Transcriptional profiling identified BATF as the bZIP transcription factor involved in TET-dependent Aicda expression. 5hmC is not deposited at TetE1 in activated Batf-deficient B cells, indicating that BATF recruits TET proteins to the Aicda enhancer. Our data emphasize the importance of TET enzymes for bolstering AID expression, and highlight 5hmC as an epigenetic mark that captures enhancer dynamics during cell activation.
Introduction
TET proteins (Ten-Eleven-Translocation; TET1, TET2, TET3) are Fe(II)-and α-ketoglutarate-dependent dioxygenases that catalyze the step-wise oxidation of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC)(1, 2). Together these oxidized methylcytosine (oxi-mC) bases are intermediates in DNA demethylation, and may also function as stable epigenetic marks. 5hmC, the most stable and abundant product of TET enzymatic activity, is highly enriched at the most active enhancers and in the gene bodies of the most highly expressed genes, and its presence at enhancers correlates with chromatin accessibility. TET proteins regulate several fundamental biological processes including lineage commitment, and play important roles in embryonic, neuronal and haematopoietic development (3) .
TET proteins, particularly TET2 and TET3, have critical roles in B cell differentiation and malignancy (2) . We and others have previously shown that deletion of the Tet2 and Tet3 with Mb1-Cre at early stages of mouse B cell development resulted in impaired light chain rearrangement and developmental blockade, and eventually developed an acute precursor-B-cell-derived leukemia with 100% penetrance (4, 5) . Inducible deletion of Tet1 and Tet2 using Mx1-Cre promoted the development of acute lymphoblastic leukemia derived from precursor B cells, and global loss of Tet1 caused B cell lymphomas with an extended latency (6) . In humans, TET2 mutations are frequently observed in Diffuse Large B Cell Lymphoma (DLBCL), a malignancy derived from germinal center B cells (7, 8) , suggesting that TET proteins may regulate mature B cell function. However, due to the pleiotropic functions of TET proteins, studies of TET-mediated gene regulation are best performed in systems where TET genes are deleted acutely rather than during development.
After their development in the bone marrow, mature B cells migrate to peripheral lymphoid tissues where they encounter antigen and follicular T helper cells in germinal centers, and participate in the generation of functional immune responses (9) . In germinal centers, B cells undergo Class Switch Recombination (CSR) to replace the constant region of immunoglobulin M (IgM) to other isotypes such as IgG 1 and IgA for distinct effector functions, and also diversify the variable regions of Ig heavy and light chains for antigen recognition in a process known as somatic hypermutation (SHM). CSR and SHM are both orchestrated by the enzyme AID (Activation-induced cytidine deaminase, encoded by Aicda) (10) (11) (12) . AID promotes CSR and SHM by generating DNA double-strand breaks at Ig switch regions and point mutations at Ig variable regions, respectively (13) . Due to its high mutagenic potential (14, 15) , AID expression is normally restricted to activated B cells, stimulated either through their B cell receptor and CD40, or through pattern recognition receptors such as TLR4 which binds lipopolysaccharide (LPS).
At the transcriptional level, induction of Aicda is tightly controlled by at least 6 conserved cis-regulatory elements (16) . A promoter-proximal region (Region I) and an intronic regulatory element (Region II or E4) function as an enhancer in activated B cells and, in the case of Region II/E4, as a silencer in non-B cells and naïve and memory B cells (17, 18) . Two additional enhancers, located at -8 kb and +13 kb relative to the Aicda transcription start site (TSS), are essential for Aicda expression in activated B cells (19) . The +13kb region (termed CNS-X, E5, or Region III) showed a dramatic increase in histone H3 acetylation after TLR4-dependent activation. Both the -8 kb and +13 kb enhancers are necessary for regulating Aicda expression, as shown by studies using bacterial artificial chromosome (BAC) transgenic mice (17, 19) . Moreover, elements at -26 kb (E1) and -21 kb (E2) are necessary for CSR in CH12F3 B cell line (20) , suggesting that the concerted action of all enhancers are required for Aicda expression. The Aicda regulatory elements are occupied by multiple transcription factors, including NFκB, PAX5, E2A, and others (18, 21) . Transcriptional activation of the Aicda gene is also coupled to cell proliferation, although the mechanistic link between these events is not fully understood (22) .
Here we have investigated the role of TET proteins at a kinetic level during B cell activation, integrating our analyses of TET proteins and 5hmC deposition with data from previous studies that have dissected the transcriptional and epigenetic changes occurring in activated B cells (20, 23) . We used the Cre ERT2 system for acute gene deletion to avoid secondary effects caused by prolonged TET deficiency during cell differentiation. We show that the TET proteins Tet2 and Tet3 are important regulators of CSR in activated murine B cells and that they function by controlling the activation-induced upregulation of AID mRNA and protein. We further demonstrate that transcriptionally, TET proteins act downstream of the bZIP transcription factor Batf, which is also induced during B cell activation with more rapid kinetics than Aicda, and binds concomitantly with TET proteins to two TET-responsive elements in the Aicda locus that we termed TetE1 and TetE2. Together, our study constitutes a comprehensive analysis of the role of TET proteins in class switch recombination in activated B cells, and provides a detailed analysis of how TET proteins influence cell activation and differentiation.
Results

Genome-wide kinetics of 5hmC deposition during B cell activation
We used CMS-IP (24, 25) to analyze the kinetics of genome-wide 5hmC distribution in murine B cells activated with LPS and IL-4, a well-characterized in vitro system for studying gene regulation (Fig. 1a) . The vast majority of 5hmC-marked regions (~160,000) were shared between pre-and post-activated B cells (Fig.  1b, Fig. S1a) ; of the ~9,500 differentially hydroxymethylated regions (DhmRs) in 72h-activated versus naïve B cells, the majority (8, 454) showed increased 5hmC (DhmR 72h-up ) whereas a much smaller fraction showed a decrease (DhmR down ) (Fig. 1b,c ). DhmRs were typically located more than 10 kb from the closest transcription start site (TSS) ( The oxidized methylcytosines produced by TET proteins are known intermediates in DNA demethylation (2, 26) . To relate changes in 5hmC to changes in DNA methylation, we compared 5hmC distribution in naïve and 72h-activated B cells with published whole-genome bisulfite sequencing (WGBS) data on B cells activated for 48h under similar conditions (20) . Although WGBS cannot distinguish 5mC and 5hmC (27) , 5hmC is typically a small fraction (1-10%) of 5mC (28) , thus we refer to the WGBS signal as "DNA methylation" here. As expected, regions that showed increased 5hmC at 24 and 48h (DhmR 24h-up , DhmR 48h-up ) also showed decreased DNA methylation at their centers at 48h (Fig. 1e) . In contrast, only about half (541/1097) of the differentially methylated regions (DMRs) with decreased DNA methylation at 48h (DMR 48h-down ) had increased 5hmC
(DhmR 72h-up , Fig. S1d-f ), indicating that changes in 5hmC are a more sensitive measure of epigenetic changes in DNA cytosine modification than changes in 5mC.
Motif enrichment analysis of sequences contained in the 8,454 DhmR 72h-up peaks (Fig. 1c) and the independent set of 1,097 DMR 48h-down regions ( Fig. S1d) showed that both sets of regions were enriched in consensus binding sequences for transcription factors of the NFκB (Rel homology domain, RHD) and basic region-leucine (bZIP) families, as well as for "composite" IRF:bZIP motifs (Fig. 1f, Fig. S1g ) (29) (30) (31) . These motifs were not significantly enriched in the DhmR 72h-down regions (<1.5-fold over background; not shown),
pointing to an association between bZIP and NFκB transcription factors and TET-mediated 5hmC deposition.
To discern the relationship between 5hmC and enhancers, naïve and activated B cell enhancers, defined by H3K4 monomethylation (H3K4me1), were stratified based on the level of H3K27 acetylation (H3K27Ac), a modification that tracks with enhancer activity (32). In both sets of enhancers, 5hmC was most highly enriched at active (H3K4me1 + H3K27Ac + ) relative to poised (H3K4me1 + H3K27Ac -) enhancers (Fig. 1g) . Moreover, more than 75% of previously identified superenhancers in activated B cells, defined by H3K27Ac, overlapped with at least one DhmR 72h-up region ( Fig. 1h) (33) . As an example, a 3' distal element at the Ccr4 locus showed activation-dependent gain of 5hmC and H3K27Ac, associated with concomitant loss of methylation at specific CpGs and increased mRNA expression ( Fig.s 1i, j) . 5hmC was also associated with accessible chromatin defined by ATAC-seq (4, 5, 34 ) (see below), and kinetic analysis of active enhancers, defined as differentially active between naïve and 48h-activated B cells by high accessibility and high H3K27Ac, showed that 5hmC level positively correlated with enhancer activity (Fig. S1h) . Together our data show that 5hmC modification and DNA demethylation correlates with enhancer activity during B cell activation.
Comparison of WT and Tet2/3 DKO B cells identifies TET-responsive regulatory elements
Tet2 and Tet3 are the two major TET proteins expressed in B cells (Fig. 2a) . To evaluate the role of TET proteins in regulating B cell function, we generated mice conditionally deficient in Tet2 and Tet3, using Cre Fig. 2b) . Both Tet2 and Tet3 were efficiently deleted in B cells (Fig. 2c) , and the YFP + cells showed similar frequencies of mature splenic follicular B cells (Fig. S2a) .
Global 5hmC levels assessed by DNA dot blot were similar in WT and Tet2/3 DKO B cells prior to activation but showed a perceptible decrease by 48h after activation, as expected since 5hmC is passively lost as a function of cell division (2, 26) (Fig. S2b) . Starting at 48h, 5hmC levels were significantly lower in Tet2/3 DKO compared to WT B cells, indicating that Tet2 and Tet3 actively oxidize 5mC to 5hmC during B cell activation (Fig. S2b) . Around 2,300 5hmC-enriched regions were significantly different between WT and DKO at 72h of activation, with substantially more regions gaining 5hmC in control compared to Tet2/3 DKO B cells at each time point examined (Fig. 2d, 2e ). Of 2,139 "TET-regulated" DhmRs with higher 5hmC in WT compared to Tet2/3 DKO B cells ("WT>DKO DhmR"), 2020 (94.4%) significantly overlapped with DhmR 72-up (2020/8454, 23.9%). Consistently, "WT>DKO DhmR" were located more than 10 kb from the TSS (Fig. S2c) , showed decreased DNA methylation at their centers (Fig. S2d) , and were enriched for NF-κB (Rel homology domain, RHD), bZIP and composite IRF:bZIP motifs (Fig. 2f ).
Tet2 and Tet3 regulate immunoglobulin class switch recombination (CSR)
To assess the effect of (Fig. 3a) . The overall percentage of germinal center (GC) B cells (CD19 + GL7 + Fas + ) was similar between WT and DKO (Fig. 3b, quantified in Fig. 3c ), indicating that acute deletion of Tet2/3 had no immediate impact on the formation of GC B cells. The most striking phenotype, however, was the consistent decrease in CSR from IgM to IgG1 in both total and NP-specific germinal center B cells ( Fig. 3d-f) , demonstrating a role for TET proteins in regulating antibody responses in vivo, particularly the CSR.
To determine if the CSR phenotype was B-cell-intrinsic, B cells from tamoxifen-treated mice were labeled with proliferation dye (Cell-trace Violet) and activated with LPS and IL-4 for 4 days (Fig. 3g) . Consistent with the CSR defect in vivo, we noticed a consistent decrease in IgG1 switching in Tet2/3 DKO B cells activated in vitro relative to WT B cells (Fig. 3h, 3i) . The impaired CSR in Tet2/3 DKO is not due to Cre activity, as similar result was observed when Cre ERT2 Tet2 +/+ Tet3 +/+ Rosa26-LSL-YFP was used as control (Fig. S3a) . The defect in CSR was cell-intrinsic, since it was also apparent when congenically-marked WT (CD45.1) and Tet2/3 DKO (CD45.2) B cells were mixed and co-cultured (Fig. S3b) . The difference was not due to altered proliferation, which was comparable between WT and Tet2/3 DKO B cells (Fig. 3h, Fig. S3c) . Correlating with the decrease in CSR from IgM to IgG1, the expression of circular γ1 transcript was decreased in Tet2/3 DKO B cells (Fig.  3j) . Further, CSR to IgA was also decreased in Tet2/3 DKO relative to WT B cells activated with anti-CD40, IL-4, IL-5, and TGFβ ( Fig. 3k-3n) . Notably, reconstitution of Tet2/3 DKO B cells with the enzymatically active catalytic domain of TET2 (Tet2CD) restored CSR from IgM to IgG1 almost to control levels, whereas an enzymatically inactive mutant of Tet2CD (Tet2CD HxD ) was ineffective ( Fig. S3d-3f) . These results indicate that Tet2 and Tet3 are required for optimal CSR both in vitro and in vivo, and that their catalytic activity is required. Fig. 3a . Consistent with the very low expression of Tet1 in mature B cells (Fig. 2a) , the CSR defect in Tet1/2/3 TKO was comparable to that observed in Tet2/3 DKO mice, with decreased IgG1-switched cells (Fig. S3g-3h) . These results indicate that Tet2 and Tet3 are the major TET proteins that regulate CSR in B cells.
Tet2 and Tet3 regulate expression of the cytidine deaminase AID
CSR is a highly regulated process and involves multiple pathways, including cytokine signaling and DNA repair (35). RNA-seq analysis identified a relatively small number of genes differentially expressed between WT and Tet2/3 DKO B cells under resting conditions and at different time points after activation (Fig. S4a, 4b) ; among these was Aicda, which encodes AID, the activation-induced cytidine deaminase essential for CSR. qRT-PCR analysis confirmed an ~50% decrease in Aicda mRNA expression in Tet2/3 DKO relative to WT B cells at each time point from 48 to 96 hours post-activation (Fig. 4a, Fig. S4c ), a phenotype reminiscent to the dampened CSR in the case of AID haploinsufficiency (36, 37) ( Fig. S4d-i) . The decrease in protein expression was even more profound, as shown by immunoblotting (Fig. 4b) .
To determine if the decrease in AID expression was fully responsible for the CSR defect, we expressed WT and catalytically inactive AID in WT and Tet2/3 DKO B cells via retroviral transduction. Prior to transduction, B cells from WT and DKO mice were stimulated for 24 hours with LPS and F(ab') 2 anti-IgM, a stimulation condition in which CSR was inhibited and AID expression was delayed (38). CSR was induced with LPS and IL-4 24h post-transduction. We argued that if Tet2 and Tet3 regulated additional major process(es) downstream of AID, re-expressing AID in Tet2/3 DKO would only have a marginal effect on the observed CSR phenotype. In fact, retroviral expression of catalytically active AID (AID WT ) largely rescued the CSR defect in Tet2/3 DKO B cells; catalytic activity was required as expression of a catalytically inactive AID mutant (AID MUT ) had no effect on CSR (bottom panels; Fig. 4c, 4d ). Similar to previous observations (12) , expression of AID in WT cells also increased the frequency of IgG1 + cells (top left and middle panels; Fig. 4c, 4d ). Despite their importance in Aicda expression, Tet2/3 were not required for the expression of µ and γ1 germline transcripts that are essential for CSR (Fig. S4j) . These data suggest that the bulk of the CSR defect in Tet2/3 DKO B cells can be attributed to the decrease in expression of Aicda mRNA and AID protein, leading us to test the hypothesis that TET proteins control Aicda expression through distal regulatory element(s) of the Aicda gene.
Identification of TET-responsive regulatory elements in the Aicda locus
Multiple conserved regulatory elements influence Aicda expression (Fig. S5a) , including an intronic region located 26 kb 5' of the Aicda TSS, within the adjacent Mfap5 gene; two intergenic regions between the Mfap5 and Aicda genes (located at -21kb and -8 kb 5' of the Aicda TSS respectively); a region in the first intron of Aicda; and a region located 3' of the Aicda gene. Deletion of any of the above elements, either in the endogenous locus or in the context of BAC transgenes, dramatically decreased the expression of Aicda in activated B cells (17) (18) (19) (20) , indicating that they have essential, non-redundant regulatory (enhancer) function and that their concerted action is necessary for Aicda induction. The Aicda 5' enhancer at -26 kb in the Mfap5 gene, the intergenic 5' enhancers, and the intron 1 enhancer noticeably gain H3K27Ac and lose 5mC upon activation, and have been collectively termed the Aicda "superenhancer" (20, 33) (Fig. 5a , middle and bottom tracks).
To determine if these regulatory elements were detectably occupied by Tet2 upon activation, we performed chromatin immunoprecipitation-sequencing (ChIP-seq) for Tet2 in B cells at 72h following activation. Indeed, each of these elements was occupied by Tet2 in 72h-activated B cells (Fig. 5a, top two tracks) . Among these, the Mfap5 intronic region and the intergenic region, located at -26 kb and -8 kb 5' of the TSS were clearly "TET-regulated": their 5hmC levels increased after activation of WT B cells, and this increase was significantly diminished in Tet2/3 DKO B cells (Fig. 5b) , placing them in the category of WT>DKO DhmRs (Fig. 2d, 2e) . We have termed these enhancers TetE1 (-8 kb) and TetE2 (-26 kb) respectively; TetE1 is potentially the prime target for Tet2/3 due to its larger gain of 5hmC after activation (Fig. 5b) .
To confirm the importance of TetE1 in Aicda regulation, we deleted the enhancer using CRISPR in CH12F3 cells, a B cell line that can class-switch from IgM to IgA upon activation with anti-CD40/IL-4/TGFβ (Fig. S5b,  5c ). We tested four clones with homozygous deletions; all showed decreased expression of Aicda mRNA, and in three of these, there was almost no detectable CSR (Fig. S5d, 5e) , confirming a previous report in the context of a BAC transgene that TetE1 was essential for Aicda expression (17) .
B cell activation induces strong DNA demethylation (loss of WGBS signal) at TetE1 (Fig. 5a) . Since bisulfite sequencing does not distinguish 5mC and 5hmC, we used oxidative bisulfite sequencing (oxBS-seq) to assess the levels of 5mC, 5hmC and unmodified C at TetE1 in WT and Tet2/3-DKO cells (neither BS-seq nor oxBSseq distinguish unmodified C from 5fC and 5caC, but these modified bases are ~10-fold and ~100-fold less abundant than 5hmC (2)). Consistent with the fact that global 5mC and 5hmC levels are similar between WT and Tet2/3 DKO B cells prior to activation (Fig. S2b) , CpGs in both TetE1 and the Aicda promoter displayed similar levels of 5mC and 5hmC prior to activation (Fig. 5c , compare 0 h panels). At 72h following activation, however, there was a substantial increase in both 5hmC and unmodified C in WT B cells, whereas Tet2/3 DKO B cells displayed little or no 5hmC and remained significantly methylated (Fig. 5c, compare 72h panels) . These results indicate that Tet2 and Tet3 regulate Aicda expression by binding to and depositing 5hmC at both 5' enhancers, TetE1 and TetE2.
Tet2 and Tet3 maintain chromatin accessibility at the Aicda Tet-responsive elements TetE1 and TetE2
Transcriptional regulatory regions are typically found in accessible regions of chromatin (39), and were shown to be marked by 5hmC during T and B cell development (4, 34) . To assess the dynamics of changes in chromatin accessibility, we performed ATAC-seq in B cells stimulated with LPS and IL-4. Activated B cells displayed progressive chromatin remodeling, with thousands of regions showing changes in accessibility compared to naïve B cells, ranging from 15,529 differentially accessible regions (DARs) at 24h to 28,106 DARs at 72h (Fig. 6a) . Regions with increased 5hmC after activation (DhmR 72h-up ) also showed increased chromatin accessibility following activation, and vice versa (Fig. S6a , blue box-and-whisker plots and not shown).
To understand the relationship between TET function and chromatin accessibility, we performed ATAC-seq on WT and Tet2/3 DKO B cells activated as in Fig. 3g . Of a total of ~28,000 accessible regions (Fig. 6b, 6c) , only a minor fraction (~1.5%; 421 of 28137) showed significant changes in accessibility between WT and Tet2/3 DKO B cells and the differences were observed late, at 72h following activation ( Fig. 6b-d) . Of the 292 potentially TET-regulated DARs, defined as showing decreased accessibility in Tet2/3 DKO compared to WT B cells (WT>DKO DARs), the majority were located distal to the TSS (Fig. S6b) and showed a Tet2/3-dependent increase in 5hmC (Fig. 6c, Fig. S6c, upper panels) . In contrast, the 129 DKO>WT DARs that were less accessible in WT compared to Tet2/3 DKO B cells, and the 27716 commonly accessible DARs, were present in both TSS-proximal and -distal regions, and did not show significant changes in 5hmC (Fig. 6c , middle and lower panels; Fig. S6b, 6c) . Analysis of DNA methylation at 48h post-activation showed that WT>DKO DARs were further demethylated after activation, whereas DKO>WT DARs were already substantially demethylated in naïve B cells and showed no further changes after activation (Fig. S6d) . Moreover, WT>DKO DARs resembled DhmR 72h-up ( Fig. 1f) and WT>DKO DhmRs (Fig. 2f) in their enrichment for bZIP and BATF:IRF motifs (Fig. S6e) .
Focusing on the Aicda locus, we found that activation was associated with increased accessibility at the Aicda enhancers TetE1 and TetE2 (Fig. 6d) . The 5hmC modification continuously increased at these two elements until 72h, with a higher level of deposition at TetE1 (see Fig. 5b ). In contrast, the time course of increase in chromatin accessibility was quite different at the two enhancers ( Fig. 6d) : TetE2 showed a rapid increase in accessibility apparent in both WT and Tet2/3 DKO B cells at 24 h following activation, whereas the time course of increase in TetE1 accessibility was slower, matching that of 5hmC deposition (compare Fig.s  5b and 6d) . Consistent with the increased accessibility, several chromatin remodelers and histone acetyltransferases including Brg1, Chd4, p300, and to a lesser extent, Gcn5, were recruited to TetE1 and TetE2 in 24h activated B cells (Fig. S6f) . Interestingly, we noticed a slight decrease in chromatin accessibility at TetE1 and TetE2 in Tet2/3 DKO B cells compared with WT cells at 72 hours, suggesting that TET proteins are important for maintaining the accessibility at these enhancers (Fig. 6e) . Together these data point to a consistent link between bZIP-family transcription factors, TET catalytic activity and chromatin accessibility that is explored in greater detail below
Batf acts upstream of TET at Aicda enhancers
Before enhancers are established during development, cell lineage specification or activation, certain key transcription factors bind to nucleosome-associated regions and recruit chromatin remodelling complexes and histone modifying enzymes to create active enhancers (32). Chromatin remodelling complexes establish accessible (nucleosome-depleted) regions, while the histone acetyltransferase p300/CBP deposits the "active" histone modification H3K27Ac (32). To identify potential pioneer transcription factors for the Aicda locus, we took advantage of our previous motif enrichment analyses (Fig.s 1f, 2f; Fig. S1g ). We had observed strong enrichment for consensus binding motifs for bZIP transcription factors, at regions that progressively gained 5hmC as a function of activation (DhmR up , Fig. 1f ), regions that lost DNA methylation upon activation (DMR Based on these data, we focused on bZIP transcription factors expressed in activated B cells. Consistent with previous observations (40, 41), Batf was expressed at low levels prior to activation but was highly expressed from 24h to 96h following activation (Fig. 7a) . This increase in Batf expression preceded that of Aidca, as expected if Batf regulated Aidca mRNA induction (Fig. S7a) . In contrast, expression of Bach1 and AP-1 (Fos and Jun) family members was either low throughout (Fosl1, Fosl2, JunD, Bach1), or moderate to high in unstimulated B cells and strongly reduced by 24h (Fos, FosB, Jun, JunB) or 72h (Bach2) of activation ( Fig. S7b-d) . Given the kinetics, we examined the importance of Batf in subsequent experiments.
Batf is essential for controlling both T and B cell function during humoral responses (40, 41). Importantly, Batf-KO B cells are defective in CSR (Fig. S7e) (40, 41) , thus resembling Tet2/3 DKO B cells (Fig. 3) . Genome-wide analysis of Batf binding by ChIP-seq in 72h-activated WT and Tet2/3-DKO B cells showed very few overall differences (Fig. S7f) , indicating that Batf functioned upstream or independently of TET enzymes. Nevertheless, one of two distinguishable sets of Batf ChIP-seq peaks (Cluster 2 in Fig. 7b ; n=9,442) was clearly TET-regulated, since the peaks in this cluster showed a progressive Tet2/3-dependent increase in 5hmC with time after activation (Fig. 7b, c) . In contrast, the majority of Batf peaks in Cluster 1 (n=2,198) showed no significant activation-dependent increase in 5hmC ( Fig. 7b; upper panel) .
Batf bound strongly at the TetE1 and TetE2 enhancers in the Aicda locus, and to a lesser extent to the -21 kb intergenic enhancer located between TetE1 and TetE2 (Fig. 7d, top tracks) . This binding pattern resembles that of Tet2 (Fig. 5a) , as well as that of E2A and PU.1 (Fig. 7d) , three transcriptional regulators already expressed in unstimulated B cells ( Fig. S7g, 7h; Fig. 2a)(21, 42, 43) . Moreover, BATF as well as JUNB associated with TetE1 and TetE2 in a human B cell lymphoblast (Fig. S7i) , suggesting the binding of BATF is evolutionarily conserved. To determine whether Batf acted upstream of TET proteins (for instance by recruiting Tet2 and Tet3 to Batf-bound regulatory regions), we analysed 5hmC deposition at the Batf-and TET-responsive element TetE1 in WT and Batf-deficient B cells. We found unambiguously that the absence of Batf abolished activation-induced hydroxymethylation at TetE1 (Fig. 7e) , indicating that Batf is required for TETmediated hydroxymethylation at this Aicda enhancer. Our results are consistent with the hypothesis that Batf recruits Tet2 and/or Tet3 to TetE1 and TetE2 and facilitates Aicda expression by promoting 5hmC modification and DNA demethylation at these upstream Aicda enhancers.
Discussion
TET proteins (TET1, TET2 and TET3) oxidize 5mC to 5hmC, a stable epigenetic mark that is the most abundant of the three oxi-mC intermediates for DNA demethylation. Due to the pleiotropic effects of TET proteins in cells, it has been challenging to address the specific roles of TET proteins in mice with prolonged TET deficiency. Here, to circumvent this issue, we used the inducible tamoxifen-Cre ERT2 system to delete Tet2
and Tet3 in mature B cells, a well-established system for the molecular analysis of gene regulation during cell activation. Our data show clearly that Tet2 and Tet3 -the major TET proteins expressed in B cells -are required for efficient class switch recombination (CSR) both in vivo and in cultured cells. A primary mechanism involves TET-mediated regulation of the expression of Aicda, the essential DNA cytosine deaminase for CSR. The activation-induced transcription factor BATF, potentially with other transcription factors, recruits TET proteins to two major TET-responsive regulatory elements that we have newly defined in the Aicda locus, TetE1 and TetE2. Tet2 and Tet3 convert 5mC to 5hmC at these regulatory elements, leading to DNA demethylation, sustaining enhancer accessibility and augmenting Aicda expression.
The biological consequences of TET loss-of-function are determined by several factors: the time course of Tet2 and Tet3 gene deletion, the stability of Tet2 and Tet3 mRNA and protein, and the rate of cell division which determines the rate of passive (i.e. replication-dependent) dilution of 5hmC. At each cell division, hemimethylated CpGs are recognised by the maintenance UHRF1/DNMT1 DNA methyltransferase complex and converted back to symmetrically methylated CpGs, whereas hemi-hydroxymethylated CpGs are ignored and so are diluted by half (1, 2). Consequently, 5hmC is present at comparable levels in quiescent (non-dividing) WT and Tet2/3 DKO B cells, thus enabling us to study the effects of acute TET deletion in activated, proliferating B cells. The progressive replication-dependent loss of 5hmC and consequent dilution of both 5mC and 5hmC is likely to be required for optimal gene expression, explaining the long-standing observation that the induction of Aicda expression during B cell activation, and the induction of cytokine genes during Th2 differentiation, are both tightly coupled to cell division (22, 44 ).
An optimal level of AID is crucial to maintain the necessary balance between effective antibody immune responses and unintentional C>T mutations caused by AID-mediated DNA cytidine deamination. Indeed, while Aicda haploinsufficiency results in dampened antibody responses (36, 37) ( Fig. S4e-j) , uncontrolled AICDA expression is associated with B cell malignancies (45). Thus, the level and activity of AID are meticulously controlled by diverse mechanisms including a tight transcriptional regulatory program (16) . At the Aicda locus, at least six regulatory elements have been identified (Fig. S5a) ; five of them, located at distances ranging from -29 to +5 kb relative to the TSS, are collectively termed the Aicda superenhancer (20, 33) . The enhancers at -26, -21, -8, +13 kb are all necessary for inducing Aicda expression in activated B cells, based on deletion of individual enhancers in mice and the CH12 B cell line (17, 18) . Notably, even in naïve B cells where Aicda is not expressed, the Aicda promoter is already highly enriched in 5hmC and the -21, intronic, +13 kb Aicda enhancers display 5hmC and H3K27Ac (Fig. S5a) . In fact, the 5hmC modification at the -26, -21, +13 kb Aicda enhancers is apparent as early as the pro-B cell stage of B cell development (4), suggesting that TETmediated 5hmC modification acts to "bookmark" regulatory elements necessary for proper gene expression in progeny cells after activation.
The vast majority of 5hmC-marked regions are present in common between naïve and activated mature B cells (this study), and between WT and TET-deficient iNKT cells (34), supporting the hypothesis that most 5hmC-marked regions in any given cell type were laid down during prior developmental stages and thus are constitutively modified. In contrast, activation-induced 5hmC modification occurs at only a few distal elements in B cells (Fig. 1c) , and 5hmC levels at these elements correlate strongly with activation-induced increases in enhancer activity defined by H3K27Ac (Fig. 1g) (46) . Moreover, the majority of previously described B cell superenhancers (20, 33) harbor at least one activation-induced, 5hmC-modified regulatory element (Fig. 1h) . In the particular case of Aicda, we identified activation-induced 5hmC modification at two major TETresponsive elements, TetE1 and TetE2, both part of a superenhancer cluster located 5'of the Aicda gene ( Fig. 5a ) (20, 33) . 5hmC modification at these elements was apparent by 48h (Fig. 5b) , preceding the dramatic upregulation of Aicda mRNA at 72h (Fig. S4c) . Loss of Tet2 and Tet3 almost eliminated the induced 5hmC modification at both enhancers and resulted in diminished expression of both Aicda mRNA and AID protein (Fig. 4a, 4b, 5b; Fig. S4c ), suggesting that TET proteins and 5hmC are required for the TetE1 and TetE2 enhancers to function at full capacity.
Studies from our lab and others have implicated TET proteins and 5hmC in regulating chromatin accessibility. For instance, TET proteins were shown to be required for demethylation of evolutionarily conserved enhancers during zebrafish development, and morpholino-mediated knockdown of Tet1/2/3 resulted in decreased enhancer accessibility (47). In mammals, we have shown that Tet2/3-deficiency results in lower accessibility of enhancers during T and B cell development (4, 34) . However, these steady state studies provide limited mechanistic insights. Here, through systematic analyses of 5hmC modification and chromatin accessibility kinetics during B cell activation, we show that 5hmC displays a time-dependent increase at regions that are differentially accessible between WT and Tet2/3 DKO B cells during; moreover TET proteins are important for sustaining enhancer accessibility ( Fig. 6e; Fig. S6e ). We speculate that enhancer methylation limits enhancer output through recruitment of repressive complexes associated with a variety of proteins that bind methylcytosine or methylated CpGs (48), and that TET-mediated CpG hydroxymethylation and subsequent DNA demethylation are required to maintain enhancer accessibility, perhaps through recruitment of CXXC domain proteins such as Cpf1, a component of the SETD1 H3K4 methyltransferase complex (49).
How the activity of TET proteins is directed to specific sites in the genome remains an open question. In a previous study, we showed that TET proteins are recruited to Ig light chain enhancers during B cell development, potentially via the transcription factors PU.1 and E2A, and documented direct protein-protein interactions of Tet2 with both E2A and PU.1 (4). Here we propose that promiscuous interaction with transcription factors is a general mechanism for recruitment of TET proteins to specific loci, similar to the known interactions of p300 with hundreds of transcription factors (50). To identify the transcription factors mediating TET recruitment in activated B cells, we took advantage of our genome-wide analyses to assess enrichment for consensus transcription factor binding motifs in multiple datasets (5hmC, ATAC and DNA methylation). We found a consistent enrichment for NFκB, bZIP and bZIP:IRF composite binding motifs ( Our data suggest strongly that the bZIP transcription factor Batf is one of the major bZIP transcription factors responsible for TET recruitment to the Aicda locus. Batf is strongly induced at the mRNA level prior to Aicda induction in activated B cells (Fig. 7a) , and Batf deficiency in B cells is associated with a dramatic impairment of AID expression and CSR (40, 41). Although loss of Tet2 and Tet3 had no significant effect on global Batf binding ( Fig. 7b; Fig. S7d ), Batf was required for 5hmC modification at TetE1 (Fig. 7e) . Composite bZIP:IRF motifs and AP-1 motifs that support BATF:JUN:IRF and BATF:JUN cooperation respectively were enriched in our genome-wide 5hmC, ATAC and DNA methylation datasets ( Fig. 1f, 2f; Fig. S1g, 6e) , consistent with previous findings that B cells lacking BATF, and IRF4/IRF8 show impaired Aicda induction and CSR (40, 41, 52-54). We propose that together, BATF:JunB and BATF:IRF assemblies recruit TET proteins as well as chromatin remodelling complexes to diverse enhancers including the Aicda enhancers TetE1 and TetE2 in activated B cells, thereby promoting enhancer accessibility, 5hmC deposition and DNA demethylation.
Our data emphasize the utility of 5hmC mapping for easy, one-step analysis of transcriptional and epigenetic landscapes in any cell type of interest. 5hmC is a quintessential epigenetic modification that marks the most highly enriched at active enhancers and the gene bodies of highly transcribed genes, and the relative levels of 5hmC at enhancers and gene bodies provide good estimates of enhancer function and the magnitude of transcription respectively (46). 5hmC mapping by CMS-IP sufficed to identify all known enhancers in the Aicda locus, in a manner that was superior to both H3K27Ac and Tet2 ChIP-seq, and changes in 5hmC identified enhancers relevant to any particular process of cell activation or differentiation separately from all enhancers in the genome. Given its high chemical stability, the fact that its measurement requires only purified DNA, and the availability of methods for its sensitive and specific detection, 5hmC is an appealing epigenetic mark for studying gene regulation. Overall, 5hmC distribution contains information analogous to those from ATAC-seq and ChIP-seq for enhancer histone modifications, effectively providing a transcriptional history of any given cell type written in DNA. If the genome is akin to an encyclopedia, 5hmC highlights those entries most relevant to a particular biological process. 
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g) Flow chart of experiment to assess CSR (IgG1 switching) in vitro. Cells were labeled with Cell-Trace violet and activated for 4 days with LPS (25 ug/mL) and rmIL-4 (10 ng/mL). (h-i) Flow cytometry plots (h) and quantification of experiments (i) show decreased frequencies of IgG1-switched B cells in
WT and Tet2/3-DKO B cells were activated as in
Materials and Methods
Mice. Tet2 fl/fl and Tet3 fl/fl mice were generated as previously described 55, 56 . C57BL/6J (000664), Ubc-CreERT2 (008085; described as Cre ERT2 herein), Rosa26-LSL-EYFP (006148), and AID-Cre (007770) were obtained form Jackson Laboratory. All mice used were 8-16 weeks in the C57BL/6 background and kept in specific-pathogen free animal facilitate at La Jolla Institute and were used according to protocols approved by the Institutional Animal Care and Use Committee. To induce Cre ERT2 -mediated deletion, Cre-expressing and control mice were intraperitoneally injected with 2 mg tamoxifen (Sigma) dissolved in 100 uL corn oil (Sigma) daily for 5 days.
Immunization. For 4-hydroxy-3-nitrophenylacetyl-conjugated ovalbumin (NP-OVA; Biosearch) immunization, the hapten-conjugated protein was diluted to 1 mg/mL in PBS was mixed with 1 volume of Alhydrogel (Invivogen) and injected into hind footpads (10 ug in 20 uL per injection). Germinal center response was analyzed 7 days later and the two draining popliteal lymph nodes were pooled for analysis. Hapten-specific B cells were identified by positive staining with NP-phycoerythrin (BioSearch Technologies). were cultured in the presence of 1 uM 4-hydroxytamoxifen (Tocris). All cytokines used above were from Peprotech (Rocky Hill, NJ).
B cell isolation and class switch recombination (CSR
Retroviral transduction and two-step CSR. Retrovirus was produced by transfecting PlatE cells with MSCV-
based retroviral vectors and pCL-Eco. Naïve B cells were stimulated with 5 ug/mL F(ab')₂ goat anti-mouse IgM (Jackson Immuno Research) and 10 ug/mL LPS at 1x10 6 cells/mL for 24-48 hours. Retrovirus was added to the cells in the presence of 20mM HEPES and 0.8 ug/mL Polybrene (Millipore) and centrifuged at 3,000 rpm at 32°C for 90 mins. Cells were transferred back to 37°C 5% CO 2 incubator for another 24 hours. To induce CSR, cells were washed once with warm media and activated with LPS and IL-4 as above for 48 hours. Under this condition, CSR was inhibited and started to class switch only after LPS/IL-4 activation.
Flow cytometry. Primary cells and in vitro cultured cells were stained in FACS buffer (1% bovine serum albumin, 1mM EDTA, and 0.05% sodium azide in PBS) with indicated antibodies for 30 mins on ice. Cells were washed and then fixed with 1% paraformaldehyde (diluted from 4% with PBS; Affymetrix) before FACS analysis using FACS Canto II and FACS LSR II (BD Biosciences). Antibodies and dye were from BioLegend, eBioscience, and BD Pharmingen. Data were analyzed with FlowJo (FlowJo LLC, Ashland, OR).
Immunoblotting. Proteins isolated from B cells with RIPA buffer were resolved using NuPAGE 4-12% Bis-Tris gel (ThermoFisher) and transferred from gel to PVDF membrane using Wet/Tank Blotting Systems (Bio-Rad). Membrane was blocked with 5% non-fat milk (Bob's red mill) in TBSTE buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 0.05% Tween-20, 1 mM EDTA), incubated with indicated primary antibodies, followed by secondary antibodies conjugated with horseradish peroxidase (HRP) and signal was detected with enhance chemiluminescence reagents and X-ray film.
RNA extraction, cDNA synthesis, and quantitative RT-PCR. Total RNA was isolated with RNeasy plus kit (Qiagen, Germnay) or with Trizol (ThermoFisher, Waltham, MA) following manufactures' instruction. cDNA was synthesized using SuperScript III reverse transcriptase (ThermoFisher) and quantitative RT-PCR was performed using FastStart Universal SYBR Green Master mix (Roche, Germany) on a StepOnePlus real-time PCR system (ThermoFisher). Gene expression was normalized to Gapdh. Primer are listed in Supplementary Table 3 .
Bisulfite-(BS) and oxidative-bisulfite-(oxBS) sequencing
The BS and oxBS procedures were performed as previously described 28 . Briefly, three PCR products containing C, mC, or hmC pertaining to different regions of ʎ phage genome were used as spike-ins at a ratio of 1:200 of the genomic DNA. 1.5 µg of genomic DNA mixed with spike-ins was ethanol precipitated of which 1 µg of the DNA was oxidized with potassium perruthenate (KRuO 4 ; Sigma) prior to bisulfite (BS) treatment (for oxBS) using MethylCode bisulfite conversion kit (ThermoFisher) and 0.5 µg of DNA was directly used for BS treatment. The BS and oxBS treated DNA were amplified using respective PCR primers and as well as primers specific to the spike-in PCR products with KAPA Uracil + PCR mix (Roche). The amplified products were pooled and libraries were prepared using the NEB Ultra II library preparation kit (NEB) according the manufacturer. The libraries were sequenced paired-end 250bp by 250bp using MiSeq with the MiSeq reagent kit v2 (500-cycles; Illumina). Primer are listed in Supplementary Table 3 .
Genome-wide 5hmC mapping by cytosine-5-methylenesulfonate immunoprecipitation (CMS-IP). CMS-IP was performed similar to perviously described 4, 24, 25 . Briefly, genomic DNA isolated from naïve and activated B cells was spiked with unmethylated lambda phage cI857 Sam7 DNA (Promega, Madison, WI) and a PCR amplicon from puromycin resistant gene at a ratio of 200:1 and 100,000:1, respectively. DNA (5-10 ug in 130 uL TE buffer) was sheared with a Covaris E220 (Covaris) using microTUBE for 4 mins. DNA was cleaned-up with AmureXP beads, processed with NEBNext End Repair and A-tail Modules (NEB, Ipswich, MA), and ligated to methylated Illumina adaptors (NEB). DNA was then bisulfite-treated (MethylCode, ThermoFisher), denatured, and immunoprecipitated with anti-CMS serum (in house) and mixture of protein A and G dynabeads (ThermoFisher). Libraries for immunoprecipitated DNA were generated by PCR with barcoded primers (NEBNext Multiplex Oligos for Illumina, NEB) for 15 cycles using KAPA HiFi HotStart Uracil+ ReadyMix (Roche), followed by a cleanup with AmpureXP beads (Beckman Coulter), and sequenced with a HiSeq2500 (Illuminia, San Diego, CA) with paired-end 50 bp reads.
Locus specific analysis of 5hmC with AbaSI-qPCR. Genomic DNA (200 ng) was treated with T4 betaglucosyltransferase (ThermoFisher) in the presence of UDP-glucose to glycosylate 5hmC at 37°C overnight. Half of the reaction was digested with AbaSI (NEB), which is specifically active for glycosylated 5hmC, for 4 hours at 25°C followed by 15 mins at 65°C to inactivate enzymes. The uncut sample was processed as above without the addition of AbaSI. Equal amount of DNA from the above reactions was used as template for real-time PCR as described for RNA qRT-PCR using primers TetE1-CMS-qF and TetE1-CMS-qR. To monitor the degree of digestion, samples were spiked-in 1 pg control DNA with a single 5hmC-modified CpG (EpiMark 5-hmC and 5-mC Analysis Kit; NEB). The relative amount of 5hmC was calculated by the percentage of decrease in qPCR signals in digested half relative to undigested half. As control to monitor non-specific digestion (not show), a genomic region containing CpG motifs but without 5hmC modification in B cells (Foxp3 CNS2) was used as a control with Foxp3-CNS2-qF and Foxp3-CNS2-qR. Primers are listed in Supplementary Table 3. DNA dot blot. DNA dot blot was performed as previously described 4, 28 . To analyze 5hmC abundance, genomic DNA was treated with sodium bisulfite as above. DNA was diluted two-fold serially with TE buffer, denatured in 0.4 M sodium hydroxide and 10 mM EDTA at 95°C for 10 mins, and then immediately chilled on ice. Equally volume of ice-cold 2 M ammonium acetate pH 7.0 was added and incubated on ice for 10 mins. Denatured DNA were spotted on a nitrocellulose membrane using a Bio-Dot apparatus (Bio-Rad), washed with 2x SSC buffer (300 mM NaCl and 30 mM sodium citrate), and baked in a vacuum oven at 80°C for 2 hours. To detect CMS, membrane was rehydrated with TBSTE buffer and blocked with 5% non-fat milk (Bob's red mill) in TBSTE buffer. CMS was detected with primary rabbit anti-CMS antisera (in house) following the procedures above for Immunoblotting.
Chromatin Immunoprecipitation sequencing (ChIP-seq).
Chromatin immunoprecipitation was performed as described before 4 . Briefly, cells were fixed with 1% formaldehyde (ThermoFisher) at room temperature for 10 mins at 1x10 6 cell/mL in media, quenched with 125 mM glycine, washed twice with ice cold PBS. Cells were pelleted, snap-froze with liquid nitrogen, and store at -80°C until use. For Tet2-ChIP, activated cells were centrifugated at 250 x g for 5 mins and cell pellets were resuspended in 37°C PBS with 2mM disuccinimidyl glutarate to crosslink proteins for 30 mins at room temperature. Formaldehyde was added to a final concentration of 1% and the cells were incubated at room temperature for 10 mins with nutation. Quenching and cell storage were performed as above. To isolate nuclei for sonication, cell pellets were thawed on ice and lysed with lysis buffer (50 mM HEPES pH 7.5, 140 mM NaCl, 1mM EDTA, 10% glycerol, 0.5% NP40, 0.25% Triton-X100) for 10 mins at 4°C with rotation, washed once with washing buffer (10 mM Tris-HCl pH 8.0, 200 mM NaCl, 1 mM EDTA, 0.5 mM EGTA) and twice with shearing buffer (10 mM Tris-HCl pH 8.0, 1 mM EDTA, 0.1% SDS). Nuclei were resuspended in 1mL shearing buffer and sonicated with Covaris E220 using 1 mL milliTUBE (Covaris, Woburn, MA) for 18-20 minutes (Duty Cycle 5%, intensity 140 Watts, cycles per burst 200). After sonication, insoluble debris was removed by centrifugation at 20,000 x g. Buffer for chromatin was adjusted with 1 volume of 2x conversion buffer (10 mM Tris-HCl pH 7.5, 280 mM NaCl, 1 mM EDTA, 1mM EGTA, 0.2% sodium deoxycholate, 0.2% Triton-X100, 1% Halt protease inhibitors with (for H3K27Ac) or without (for BATF, Tet2) 0.1% SDS. Chromatin was pre-cleared with washed protein A dynabeads (ThermoFisher) for 2 hours, incubated with antibodies and protein A dynabeads overnight (all procedures were at 4°C with rotation). For H3K27Ac ChIP, bead-bound chromatin was washed twice with RIPA buffer (50 mM Tris-HCl pH 8.0, 150 mM NaCl, 1 mM EDTA, 0.5% sodium deoxycholate, 1% NP-40, 0.1% SDS), once with high salt wash buffer (50 mM Tris-HCl pH 8.0, 500 mM NaCl, 1 mM EDTA, 1% NP-40, 0.1% SDS), and once with TE (10 mM TrisHCl pH 8.0, 1 mM EDTA). For BATF ChIP, all wash buffers were as above but without SDS. For Tet2 ChIP, beads were washed three times with RIPA buffer without SDS and once with TE. Chromatin was eluted from beads with elution buffer (100 mM NaHCO 3 , 1% SDS, 1 mg/mL RNaseA; Qiagen) twice for 30 mins each at 37°C with constant shaking. NaCl and proteinase K (Ambion) were added to the eluted chromatin at concentrations of 250 mM and 0.5 mg/mL, respectively, and de-crosslinked at 65°C overnight with constant shaking. DNA was purified with Zymo ChIP DNA Clean & Concentrator-Capped Column (Zymo Research, Irvine, CA). Library was prepared with NEB Ultra II library prep kit (NEB) following manufacture's instruction and was sequenced on an Illumina Hiseq 2500 (single-end 50 bp reads).
ATAC-seq. Procedures were as described 4 . Briefly, 50,000 cells were collected by centrifugation and washed once with 50uL ice-cold PBS and centrifuged at 600 xg for 5 mins at 4°C. Cell pellets were resuspended in 50 uL of cold lysis buffer (10mM Tris-HCl pH 7.4, 10 mM NaCl, 3 mM MgCl 2 , 0.1% IGEPAL CA-630) and spin down immediately at 500 xg for 10 mins at 4°C. Supernatant was discarded and nuclei were resuspended in 50uL transposition reaction mix (25uL 1x TD buffer fom Illuminia, 2.5 uL Tn5 transposase, 22.5 uL H 2 O), incubated at 37°C for 30 mins, and DNA was purified with a Qiagen MinElute kit (Qiagen). Library was amplified with KAPA HiFi HotStart Real-time PCR Master Mix (Roche) using indexed primers and sequenced on an Illumina Hiseq 2500 (paired-end 50 bp reads).
RNA-sequencing with Smart-seq. Smart-seq was performed as described previously 34, 57 . Briefly, total RNA was isolated from naïve and activated B cells with Trizol (ThermoFisher) and the integrity of the RNA was accessed with TapeStation RNA Analysis ScreenTape or Bioanalyzer RNA pico kit (Agilent). 10ng of RNA was reverse transcribed using oligo-dT 30 VN primer in the presence of Template Switching Oligo (TSO) with SuperScript II reverse transcriptase. cDNA was pre-amplified with IS PCR primers and PCR products were cleaned up with Ampure XP beads. One ng of PCR product was used to generate library using NexteraXT library prep kit (Illumina) and tagmentated DNA was amplified for a 12 cycles PCR and purified with AmpureXP beads. Libraries were sequenced on an Illumina Hiseq 2500 with single-end 50 bp reads.
Statistical analyses. Statistical analyses and bar plots were performed and plotted with Prism 7 or R (v3.3.3). Bar graph and dot plots shown indicate mean and standard error.
Materials and Methods ---Bioinformatics analyses
The reference genome used was mm10. Heatmaps and profile plots were generated using DeepTools 58 .
CMSIP analysis
Paired-end reads (50bp) were mapped to the mouse genome mm10 GRCm38 (Dec. 2011) from UCSC, using BSMAP (V.2.74) (-v 4 -R -n 1 -w 2 -r 0 -q 20 -R -p 8) 59 . Reads that mapped to the spike-in control (Lambda and Puro) were filtered out from the Sam file using awk. Tag directories were created with the remaining reads using makeTagDirectory from HOMER 60 (-genome mm10 -tbp 1 -checkGC). Peaks were called with findPeaks from HOMER (-style histone -o auto -i). Peaks from all samples were merged with mergePeaks from HOMER into a master table. Quantile normalization was applied to all raw counts files and differentially enriched 5hmC regions were identified with edgeR 61 ; a p adjusted value of ≤ 0.05 was used as a cutoff.
H3K27Ac ChIP analysis
Single end reads (50bp) were mapped to the mouse genome mm10 GRCm38 (Dec. 2011) from UCSC with Bowtie (V.1.1.2). Reads were sorted and PCR duplicates were removed using SortSam and MarkDuplicates, respectively from Picard Tools (V.2.7.1). Tag directories were created with makeTagDirectory (-genome mm10 -checkGC) from HOMER, and peaks were called with findPeaks (-region). Peaks from all samples were merged with mergePeaks from HOMER into a master table. Quantile normalization was applied to all raw counts files and differentially enriched 5hmC regions were identified with edgeR 61 ; a p adjusted value of ≤ 0.05 was used as a cutoff.
BATF ChIP analysis
Single end reads (50bp) were mapped to the mouse genome mm10 GRCm38 (Dec. 2011) from UCSC with Bowtie (v1.1.2). Reads were sorted and PCR duplicates were removed using SortSam and MarkDuplicates, respectively from Picard Tools (V.2.7.1). Tag directories were created with makeTagDirectory (-genome mm10 -checkGC) from HOMER 60 , and peaks were called with findPeaks (-style factor -o auto).
Definition of preferentially active enhancers
Preferentially active enhancers (Supplementary Fig. 1h ) were defined as distal H3K27Ac regions (> 1kb from TSS) that had ATAC-seq and H3K27Ac peaks overlapping in at least 50% of either peak/region; overlapping was calculated with intersectBed -f 0.5 -f 0.5 -e (Bedtools v2.26.0). The differential enrichment in an enhancer was called if it contains a differentially enriched H3K27Ac region as well as at least one differentially access region.
ATAC-seq analysis
Paired-end reads (100 bp) were mapped to the mouse genome mm10 GRCm38 (Dec. 2011) from UCSC using Bowtie 1.0.0 ("-p 8 -m 1 --best --strata -X 2000 -S --fr --chunkmbs 1024."). Reads that failed this alignment step were filtered for Illumina adapters and low quality using "Trim Galore!" ("--paired --nextera --length 37 --stringency 3 --three_prime_clip_R1 1 --three_prime_clip_R2 1") and re-mapped using the same parameters. Both mapping results were merged and processed together to remove duplicates using picard-tools-1.94 MarkDuplicates. Mitochondrial and Chromosome Y reads were excluded. Subnucleosomal fragments were obtained with SAMtools and awk to identify DNA fragments that were less than or equal to 100 nt in length. These fragments were used to call peaks using HOMER (v4.9.1) findPeaks function for each replicate ("-size 500 -region -center -P .1 -LP .1 -poisson .1 -style dnase") and all the peak sets were merged to generate a global set. Peaks overlapping with ENCODE blacklisted regions 62 were removed. From each sample, Tn5 insertion sites were obtained by isolation of the initial 9bp of mapped reads 63 which were used to compute the number of transposase insertions per peak using MEDIPS 64 . Raw reads from all samples were quantile-normalized prior to differential coverage analysis using edgeR without TMM (Trimmed mean of M-values) normalization. Only regions with more than 32 normalized reads across the samples per comparison. Differentially accessible regions were defined by an adjusted p value (FDR) lower than 0.05 and a log 2 fold enrichment higher equal than 1.
OxBS analysis
OxBS-seq reads were mapped to both the mouse genome mm10 GRCm38 (Dec. 2011) from UCSC and the phage Lambda genome (GenBank: J02459.1) using bsmap-2.90 (" -v 15 -w 3 -p 4 -S 1921 -q 20 -A AGATCGGAAGAGC -r 0 -R -V 2 "). The mapping results were separated into reads belonging to the mm10 genome and each of the three loci from lambda used for oxidation and conversion efficiency calculation. Methylation calls from lambda-and mm10-derived reads were obtained using bsmap-2.90 function methratio.py (" -u -p -g -i "correct" -x CG,CHG,CHH "). Conversion efficiencies as well as posterior probabilities of methylation, hydroxymethylation and unmodified cytosine were calculated by luxGLM v.0.666 (prior probabilities used for for C, hmC and mC "998,1,1", "6,2,72" and "1,998,1" respectively) 65 . Following genomic positions from lambda used for oxidation and BS treatment efficiencies:
chrLambda:22893-23053 C; chrLambda:23765-23925 hmC; chrLambda:47335-47495 mC. Consequently, a maximum of three stacked reads at the same genomic location were allowed and kept for further analysis. In addition, BSeQC was employed for removing DNA methylation artifacts introduced by end repair during adaptor ligation. Overlapping segments of two mates of a pair were reduced to only one copy to avoid considering the same region twice during the subsequent DNA methylation quantification. To estimate CpG DNA methylation at both DNA strands, methratio.py script was executed from BSMAP (v2.90) (-u -r -z -g -i "correct" -x CG). To identify differentially methylated cytosines and regions (DMCs and DMRs), a naïve B cells dataset and was compared to a activated B cell replicate using RADmeth methpipe-3.4.2 (adjust -bins 1:100:1 ; merge -p 0.05) 67 .
WGBS analysis
RNA-seq analysis RNA-seq samples at four different time-points collected from WT and DKO conditions were first mapped to the mouse genome mm10/GRCm38 using both Hisat2 68 ("--no-mixed --no-discordant --add-chrname -dta") and Tophat2 69 ("--no-novel-juncs") alignment programs separately. Aligned bam files obtained from both the programs were further used to generate the Hisat2-and Tophat2-specific counts using HTseq-count program 70 (default parameters). Hisat2-and Tophat2-specific count files at each time point for WT and DKO conditions were then used to identify the differentially expressed genes (FDR < 0.05) between matching time points using edgeR program 61 . Potential batch effects were removed using svaseq program 71 . Finally, the common differentially expressed genes obtained from both Hisat2-and Tophat2-specific list were used to perform the downstream analysis.
Genome-browser track generation for ChIP-seq
ChIP-seq results from Tet2, Ig control, E2A, PU.1, p300, and GCN5 were processed as follow to generate the genome browser tracks. Fastq files were mapped to mm10 reference genome with Bowtie 2 (v2.1.0) with "-verysensitive". The mapped SAM files were converted to BAM using Samtools (v1.7) view -h -F 4, and duplicates were removed using Picard (v2.7.1). BigWig files were made by first generating a BedGraph files from the filtered Bam files using Bedtools (v2.26.0) genomecov followed by bedGraphToBigWig (v4) with read counts normalized to 10,000,000 reads.
Miscellaneous analyses of regions
For distance between regions to the closest TSS was analyzed with HOMER software with "annotatePeaks.plannStats". Overlap between regions was analyzed by "bedtools intersect" with no requirement for the degree of overlapping. The degree of significance for overlap between superenhancers and test regions was estimated by Fisher exact test using "bedtools fisher".
Time-series analysis
For a unified analysis of the RNA-seq time-course data (0hr to 96hr) from WT samples, TCseq package 72 was used on the combined RNA-seq read counts, obtained after applying Tophat2 69 and Hisat2 68 alignment programs (Described in the previous RNA-seq analysis part). TCseq utilizes GLM method implemented in edgeR package 61 to detect the differential events in gene expression. Differential analysis was performed between "0hr" to the rest of the time points, and the significant differential events were extracted whenever a log2FC > 2 or < -2 and FDR < 0.05 criteria was satisfied. To detect the temporal pattern of the differential gene expressions (RPKM values), a soft clustering algorithm implemented in TCseq program was applied ("algo = 'cm', k = 6, standardize = TRUE"). Finally, the differential genes were assigned to a cluster (C1-C6) representing a specific temporal pattern of expression, if the membership probability of the genes to a cluster is 0.5 or more. 
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